The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effectsGiuliana Cassinelli, Franco Zunino, Giovanna Petrangolini et al.|Biochemical Pharmacology|2012Cited by 31